期刊文献+

Ufd1基因沉默逆转SW1116/HCPT细胞株对羟基喜树碱耐药的研究 被引量:2

Study of Ufd1 Gene Silencing on Reverse of SW1116/HCPT Cell Line Resistance to Hydroxycamptothecin
下载PDF
导出
摘要 背景:泛素融合降解1样蛋白(Ufd1)在蛋白质逆向转运中发挥一定作用。前期研究发现羟基喜树碱(HCPT)耐药人结肠癌细胞株SW1116/HCPT Ufd1表达增高。目的:探讨Ufd1基因沉默在逆转SW1 116/HCPT细胞株对HCPT耐药性中的作用。方法:干扰组SW1116/HCPT细胞转染Ufd1特异性siRNA以沉默Ufd1基因,对照组转染非特异性siRNA。体外药物敏感性试验检测细胞对HCPT的敏感性,流式细胞术检测细胞周期,比色法测定caspase-3活性,蛋白质印迹法检测p-JNK、p53表达情况和细胞内泛素化蛋白贮留情况。结果:干扰组SW1116/HCPT细胞对HCPT的敏感性显著高于对照组(P<0.05)。经HCPT作用,干扰组和对照组细胞均出现S期阻滞、caspase-3活性增高和p-JNK、p53、泛素表达增加,干扰组更为明显。结论:以RNA干扰技术沉默Ufd1基因可逆转SW1116/HCPT细胞株对HCPT的耐药性,推测该作用可能与活化JNK信号通路、上调p53表达以及致细胞内泛素化蛋白贮留而破坏细胞内蛋白代谢的协调性有关。 Ubiquitin fusion-degradation 1 like protein (Ufdl) plays a role in the retro-translocation of proteins. Preliminary studies have shown that Ufdl was up-regulated in hydroxycamptothecin (HCPT)-resistant human colon cancer cell line SW1116/HCPT. Aims: To study the role of Ufdl gene silencing on reverse of SW1116/HCPT cell line resistance to HCPT. Methods: SWlll6/HCPT celIs were transfected with plasmid containing Ufdl-specific siRNA (intervention group) or Ufdl-non-specific siRNA (control group). In vitro drug sensitivity test was performed to assess the sensitivity of ceils to HCPT. Flow cytometry was used for analysis of cell cycle, and colorimetry was conducted for detection of caspase- 3 activity. Western blotting was performed to assess the expressions of p-JNK, p53 and cytosolic retention of ubiquitinated proteins. Results: SW1116/HCFF cells in intervention group was much sensitive to HCPT than ceils in control group (P〈 0.05). S-phase arrest, activation of caspase-3, and up-regulation of p-JNK, p53 and ubiquitin were seen in both intervention group and control group when treated with HCPT. The above-mentioned changes were more significant in intervention group than in control group. Conclusions: RNA interference of Ufdl can reverse the resistance of SW1116/ HCPT cell line to HCPT. The mechanism is presumed to be related with activation of JNK pathway, up-regulation of p53, and cellular protein metabolism disturbance induced by cytosolic retention of ubiquitinated proteins.
出处 《胃肠病学》 2011年第10期580-584,共5页 Chinese Journal of Gastroenterology
基金 上海市重点学科建设项目(No.Y0205) 国家自然科学基金项目(No.30770964) 上海市科委重点实验室项目(No.06DZ22027) 杨森科学基金项目资助
关键词 结直肠肿瘤 羟基喜树碱 多药耐药相关蛋白质类 泛素类 基因 Ufd1 RNA干扰 Colorectal Neoplasms Hydroxycamptothecin Multidmg Resistance-Associated Proteins Ubiquitins Genes, Ufdl RNA Interference
  • 相关文献

参考文献17

  • 1邹健,冉志华,黄美兰,萧树东.人结肠癌羟基喜树碱耐药细胞株SW1116/HCPT的建立与鉴定[J].胃肠病学,2006,11(6):327-331. 被引量:10
  • 2冉志华,邹健,萧树东.人结肠癌羟基喜树碱多药耐药细胞的蛋白质组学研究[J].中华消化杂志,2007,27(7):454-456. 被引量:2
  • 3Pizzuti A, Novelli G, Ratti A, et al. UFD1L, a developmentally expressed ubiquitination gene, is deleted in CATCH 22 syndrome. Hum Mol Genet, 1997, 6 (2):259-265.
  • 4Wang Q, Li L, Ye Y. Inhibition of p97-dependent protein degradation by Eeyarestatin I . J Biol Chem, 2008, 283 (12): 7445-7454.
  • 5Heubes S, Stemmann O. The AAA-ATPase p97-Ufdl- Npl4 is required for ERAD but not for spindle disassembly in Xenopus egg extracts. J Cell Sci, 2007, 120 (Pt 8): 1325-1329.
  • 6Pye VE, Beuron F, Keetch CA, et al. Structural insights into the p97-Ufdl-Np14 complex. Proc Natl Acad Sci U S A, 2007, 104 (2): 467-472.
  • 7Ballar P, Shen Y, Yang H, et al. The role of a novel p97/ valosin-containing protein-interacting motif of gp78 in endoplasmic reticulum-associated degradation. J Biol Chem, 2006, 281 (46): 35359-35368.
  • 8Ullmannova V, Haskovec C. Gene expression during camptothecin-induced apoptosis in human myeloid leukemia cell line ML-2. Neoplasma, 2004, 51 (3): 175- 180.
  • 9Costa-Pereira AP, McKenna SL, Cotter TG. Activation of SAPK/JNK by camptothecin sensitizes androgen- independent prostate cancer cells to Fas-induced apoptosis. Br J Cancer, 2000, 82 (11): 1827-1834.
  • 10Paulovich AG, Toczyski DP, Hartwe11 LH. When checkpoints fail. Cell, 1997, 88 (3): 315-321.

二级参考文献49

  • 1Sinha P, Kohl S, Fischer J, et al. Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresis. Electrophoresis, 2000, 21(14): 3048~3057
  • 2Yin M B, Guo B, Voigt W, et al. Novel cellular determination for reversal of multidrug resistance in cells expressing of p170- glycoprotein. Biochem Biophys Acta, 1998, 1401: 265~276
  • 3Cullen K J, Newkirk K A, Schumaker L M, et al. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cancer Res, 2003, 63: 8097~8102
  • 4Dingemans A C, Van A J, Span S, et al. Topoisomerase Ⅱalpha and other drug resistance markers in advanced non-small cell lung cancer. Lung Cancer, 2001, 32: 117~128
  • 5Gregorc V, Ludovini V, Pistola L, et al. Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancer. Lung Cancer, 2003, 39: 41~48
  • 6Raval G N, Bharadwaj S, Levine E A, et al. Loss of expression of tropomyosin-1, a novel class Ⅱ tumor suppressor that induces anoikis, in primary breast tumors. Oncogene, 2003, 22(40): 6194~ 6203
  • 7Deng H B, Parekh H K, Chow K C, et al. Increased expression of dihydrodiol dehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells.J Biol Chem, 2002, 277(17): 15035~ 15043
  • 8Pawlak G, McGarvey T W, Nguyen T B, et al. Alterations in tropomyosin isoform expression in human transitional cell carcinoma of the urinary bladder. Int J Cancer, 2004, 110(3): 368~373
  • 9He Q Y, Chen J, Kung H F, et al. Identification of tumor-associ- ated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics, 2004, 4(1): 271~278
  • 10Somiari R I, Sullivan A, Russell S, et al. High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast. Proteomics, 2003, 3(10): 1863~1873

共引文献17

同被引文献34

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部